BioDelivery Sciences International Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and BioDelivery Sciences are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days BioDelivery Sciences International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, BioDelivery Sciences is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Quick Ratio | 2.04 | |
| Fifty Two Week Low | 2.50 | |
| Target High Price | 10.00 | |
| Fifty Two Week High | 5.62 | |
| Target Low Price | 4.00 |
BioDelivery |
BioDelivery Sciences Relative Risk vs. Return Landscape
If you would invest (100.00) in BioDelivery Sciences International on January 24, 2024 and sell it today you would earn a total of 100.00 from holding BioDelivery Sciences International or generate -100.0% return on investment over 90 days. BioDelivery Sciences International is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than BioDelivery, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
BioDelivery Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioDelivery Sciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BioDelivery Sciences International, and traders can use it to determine the average amount a BioDelivery Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BDSI |
Based on monthly moving average BioDelivery Sciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioDelivery Sciences by adding BioDelivery Sciences to a well-diversified portfolio.
BioDelivery Sciences Fundamentals Growth
BioDelivery Stock prices reflect investors' perceptions of the future prospects and financial health of BioDelivery Sciences, and BioDelivery Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioDelivery Stock performance.
| Return On Equity | 28.51 | |||
| Return On Asset | 10.41 | |||
| Profit Margin | 18.81 % | |||
| Operating Margin | 24.32 % | |||
| Current Valuation | 271.19 M | |||
| Shares Outstanding | 98.8 M | |||
| Price To Earning | 19.28 X | |||
| Price To Book | 4.50 X | |||
| Price To Sales | 3.33 X | |||
| Revenue | 165.72 M | |||
| EBITDA | 47.16 M | |||
| Cash And Equivalents | 100.71 M | |||
| Cash Per Share | 1.02 X | |||
| Total Debt | 58.72 M | |||
| Debt To Equity | 0.48 % | |||
| Book Value Per Share | 1.24 X | |||
| Cash Flow From Operations | 38.3 M | |||
| Earnings Per Share | 0.29 X | |||
| Total Asset | 102.77 M | |||
| Retained Earnings | (376.24 M) | |||
| Current Asset | 92.54 M | |||
| Current Liabilities | 28.08 M | |||
Things to note about BioDelivery Sciences performance evaluation
Checking the ongoing alerts about BioDelivery Sciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BioDelivery Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioDelivery Sciences is not yet fully synchronised with the market data | |
| BioDelivery Sciences has some characteristics of a very speculative penny stock | |
| BioDelivery Sciences has a very high chance of going through financial distress in the upcoming years | |
| About 69.0% of the company shares are held by institutions such as insurance companies |
- Analyzing BioDelivery Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioDelivery Sciences' stock is overvalued or undervalued compared to its peers.
- Examining BioDelivery Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioDelivery Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioDelivery Sciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioDelivery Sciences' stock. These opinions can provide insight into BioDelivery Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in BioDelivery Stock
If you are still planning to invest in BioDelivery Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioDelivery Sciences' history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |